ApprovalTrail

Approval · Notice of Compliance 5086 · 1995

ORAFEN: Notice of Compliance 5086

Issued May 15, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5086
Date
May 15, 1995
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Non-steroidal anti-inflammatory, analgesic agent

Products in this notice

BrandDINStatus today
ORAFEN02165481Cancelled Post Market

Medicinal ingredients